Medical Scientist Training Program

医学科学家培训计划

• 批准号: 9924573
• 负责人: DIANNA M MILEWICZ
• 金额: $ 17.83万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-07-01 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9924573
• 关键词: Medical; Scientist; Training Programs

PROJECT SUMMARY The mission of our multi-institutional MD/PhD Program, comprised of the University of Texas Health Science Center at Houston McGovern Medical School (UTHealth) and MD Anderson Cancer Center (MDACC), and in conjunction with the University of Puerto Rico Medical Sciences Campus School of Medicine (UPR), is to pursue novel training of a diverse group of intellectually gifted students for careers as physician-scientists focused on disease-oriented research and bridging the knowledge gap between medicine and basic science. The MD/PhD program has been continuously funded since 1982 and has graduated 105 students, including a current Director of our program. To expand diversity in our physician-scientist trainees, we have partnered with the UPR, leveraging a NIH-funded MDACC/UPR U54 Partnership for Excellence in Cancer Research award to integrate into our MD/PhD Program those talented UPR medical students who want to pursue research careers, and approximately 30% of our program is underrepresented minorities (URM). Applications to our program from students from across the country have doubled over the past 10 years, allowing us to matriculate a group of highly qualified students (51 students currently in the program). To prepare physician-scientists to pursue disease-oriented research, a novel educational sequence was established to integrate the medical and graduate school. Although students begin to fulfill graduate school requirements from the very beginning of the program, they complete the clinical specialty rotations before pursuing dissertation research. Students can select from 9 graduate training programs in biomedical sciences. Support for this educational sequence is provided by the fact that, in the past 10 years, attrition from the program has been 4% and the time to completion is 7.8 years. The quality of students and the program are exemplified by strong publication records and excellent residency matches. A major element to enhance training is the Topics in Molecular Medicine course, which provides vertical integration and community for the students, exposure to the breadth and depth of research at the institutions, and insights into career development and leadership. Based on graduates over the past 15 years, the majority of our post-training trainees are in academic positions or industry (76%; n = 38; 28 academic positions + 1 in industry). MSTP support is requested for a total of 6 matriculating students per year by year 3 of the training grant period, to expand the number of students in this unique and diverse training program.

项目概要 我们的多机构医学博士/博士项目的使命，由德克萨斯大学健康科学分校组成 休斯顿麦戈文医学院 (UTHealth) 和 MD 安德森癌症中心 (MDACC) 中心，以及 与波多黎各大学医学科学校区医学院 (UPR) 合作， 追求对不同群体的智力天才学生进行新颖的培训，使其成为医师科学家 专注于以疾病为导向的研究，弥合医学与基础科学之间的知识差距。 该MD/PhD项目自1982年以来持续资助，已毕业105名学生，其中包括一名 我们的项目现任主任。为了扩大我们的医师科学家实习生的多样性，我们与 UPR，利用 NIH 资助的 MDACC/UPR U54 癌症研究卓越合作奖 将那些想要从事研究的有才华的 UPR 医学生纳入我们的医学博士/博士课程 我们的计划中大约 30% 是针对代表性不足的少数群体 (URM)。应用到我们的 过去 10 年，来自全国各地学生的项目数量增加了一倍，使我们能够入学 一群高素质的学生（目前该项目有 51 名学生）。让医生科学家做好准备 追求以疾病为导向的研究，建立了一种新颖的教育序列，以整合医学和 研究所。尽管学生从一开始就满足研究生院的要求 计划中，他们在进行论文研究之前完成临床专业轮转。学生可以 从 9 个生物医学科学研究生培训项目中进行选择。对这一教育序列的支持是 事实证明，在过去 10 年中，该计划的人员流失率为 4%，并且需要时间 完工时间为7.8年。学生和课程的质量通过强大的出版记录得到体现 以及出色的居住比赛。加强培训的一个主要内容是分子医学主题 课程，为学生提供垂直整合和社区，接触广度和深度 机构的研究，以及对职业发展和领导力的见解。基于毕业生 在过去 15 年中，我们的大多数培训后学员都在学术职位或行业中工作（76%；n = 38； 28 个学术职位 + 1 个工业职位）。每个项目总共 6 名预科学生请求 MSTP 支持 在培训资助期的第3年，扩大参加这种独特而多样化培训的学生数量 程序。